These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 6221547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
    Ogawa K, Sakai K, Ito T, Watanabe J, Satake T.
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
    [No Abstract] [Full Text] [Related]

  • 3. Altered sensitivity to prostacyclin may be involved in the exercise-induced activation of platelets in patients with ischemic heart disease.
    Kishi Y, Numano F, Oniki T, Yajima M, Numano F.
    Prog Clin Biol Res; 1989; 301():181-5. PubMed ID: 2508101
    [No Abstract] [Full Text] [Related]

  • 4. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C, Sinzinger H, Silberbauer K, Stummvoll HK.
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary excretion rate of 6-keto-prostaglandin F1 alpha as an index of circulating prostacyclin.
    Seyberth HW, Müller H, Soeding K, Wille L, Hackenthal E.
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():533-8. PubMed ID: 6221575
    [No Abstract] [Full Text] [Related]

  • 8. Ischemia-reperfusion injury in an ischemic rat liver model: relationship between oxygen-derived free radicals and prostaglandins.
    García-Valdecasas JC, Cugat E, Almenara R, Grande L, Angas J, Fuster J, Visa J.
    Transplant Proc; 1990 Apr; 22(2):523-6. PubMed ID: 2109385
    [No Abstract] [Full Text] [Related]

  • 9. Role of prostacyclin in the response of cerebral blood flow to CO2.
    Uyama O, Nagatsuka K, Fukunaga R, Kusunoki M, Takano T, Yoneda S, Kimura K, Abe H.
    Brain Res; 1983 Jan 24; 259(2):344-7. PubMed ID: 6402270
    [Abstract] [Full Text] [Related]

  • 10. Release of prostacyclin into the coronary venous blood in patients with coronary arterial disease.
    Kaijser L, Nowak J, Patrono C, Wennmalm A.
    Adv Myocardiol; 1983 Jan 24; 4():371-8. PubMed ID: 6344165
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M, Kuzuya T, Ohmori M.
    Rinsho Byori; 1983 Aug 24; 31(8):854-9. PubMed ID: 6361336
    [No Abstract] [Full Text] [Related]

  • 13. Prostacyclin is not a circulating hormone in man.
    Blair IA, Barrow SE, Waddell KA, Lewis PJ, Dollery CT.
    Prostaglandins; 1982 Apr 24; 23(4):579-89. PubMed ID: 7051184
    [Abstract] [Full Text] [Related]

  • 14. Influence of prostaglandins upon adenosine release and of adenosine upon prostaglandin release in the isolated rabbit heart.
    Zehl U, Ritter C, Förster W.
    Acta Biol Med Ger; 1976 Apr 24; 35(11):K77-K82. PubMed ID: 1022127
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of PGI2 by 15-hydroxyprostaglandin-dehydrogenase and delta 13-reductase in different vascular beds of the cat in vivo.
    Förstermann U, Neufang B, Hertting G.
    Prostaglandins; 1981 Dec 24; 22(6):915-32. PubMed ID: 6278537
    [No Abstract] [Full Text] [Related]

  • 16. Coronary flow regulation in patients with ischemic heart disease: release of purines and prostacyclin and the effect of inhibitors of prostaglandin formation.
    Edlund A, Berglund B, van Dorne D, Kaijser L, Nowak J, Patrono C, Sollevi A, Wennmalm A.
    Circulation; 1985 Jun 24; 71(6):1113-20. PubMed ID: 3888437
    [Abstract] [Full Text] [Related]

  • 17. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP, Shebuski RJ, Aiken JW.
    J Pharmacol Exp Ther; 1980 Feb 24; 212(2):246-52. PubMed ID: 6985960
    [No Abstract] [Full Text] [Related]

  • 18. Increased myocardial release of prostacyclin in dogs with heart failure.
    Newman WH, Frankis MB, Halushka PV.
    J Cardiovasc Pharmacol; 1983 Feb 24; 5(2):194-201. PubMed ID: 6188889
    [No Abstract] [Full Text] [Related]

  • 19. Ethical problems.
    Smithells RW.
    Arch Dis Child; 1982 Dec 24; 57(12):965. PubMed ID: 6758709
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of PGI2 in patients with ischemic heart disease--coronary dilator action of prostacyclin and dissolution of coronary spasms observed in coronary angiography].
    Saito S, Tsuzi M, Tamura Y, Tomobe K, Tokutake E, Yumikura S, Hibiya K, Yamamoto M, Ichikawa M, Honda M, Ozawa Y, Hatano M.
    Kokyu To Junkan; 1982 Oct 24; 30(10):1033-8. PubMed ID: 6760309
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.